Press Releases

• ANI Pharmaceuticals: Publication of NEW DAY Clinical Trial Results in Ophthalmology More
• Biocon: U.S. Commercial Launch of Bosaya and Aukelso, Denosumab Biosimilars More
• Cipla: Expands U.S. Respiratory Portfolio With Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis More
• Curanex: Patient Case Study Supporting Potential of Phyto-N in Cancer Cachexia and Advanced Cancer Supportive Care More
• Delcath Systems: Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO–EURACAN Clinical Practice Guidelines for Uveal Melanoma More
• electroCore: First Patient Enrollment in Investigator-Led Study of gammaCore nVNS for PTSD More
• Feinstein Institutes: Researcher Spotlights Safer, Game-Changing Pulmonary Embolism Therapy More
• Feinstein Institutes: 2026 Ross Prize Awarded to Drs. Michel Sadelain and Carl H. June More
• IAVI: Begins First-in-Human Phase 1 Trial of Single-Dose Marburg Virus Vaccine Candidate More
• Intelligent Bio Solutions: Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market More
• Novo Nordisk: Wegovy Pill Demonstrated Greater Weight Loss Than Orforglipron and Lower Odds of Stopping Medication Due to Side Effects in a New Indirect Comparison to Be Presented at Obesity Medicine Association 2026 More
• OKYO Pharma: Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting More
• Regeneron: Collaborates With TriNetX to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions More
• Regeneron: EYLEA HD (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF With Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME) More
• The Michael J. Fox Foundation for Parkinson's Research: Leading Parkinson’s Organizations Urge Congress to Preserve Progress and Strengthen Parkinson’s Research Funding at the National Institutes of Health More

Financial News

• ­­
• Amneal: $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month More
• Anthropic Acquires Stealth AI Startup Coefficient Bio in $400M Deal: Reports More More
  
• Celldex Therapeutics: Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares More
  
• Dianthus Therapeutics: Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) More
• Hoth Therapeutics: Closing of $2.0 Million Registered Direct Offering More
• IN8bio: Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) More
• Matinas BioPharma: Receives Notice of Non-Compliance With NYSE American Continued Listing Standards More
• Mesoblast: Ryoncil Continues Successful First Year Launch With Net Sales of US$30.3M in March Quarter More
• OS Therapies: Completes $5.25M Registered Direct Offering Primarily With Pre-Existing High-Net-Worth Investors More
• Syndax Pharmaceuticals: Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) More

Media/Misc Coverage

• BioPharmGuy News: Moon Rocket, Fake Masters, Organ Sacks, Fly Brain, Dead Tortoise More
• Biotech Hangout: Episode 178 Podcast
• Rover Diagnostics Takes Last Space at Queens Life-Sciences Building Innolabs More*
  
• Subscribe to LifeSci Startup for Updates on US Startups More
• The Rockefeller University: A New Mouse Model of Virus-Driven Liver Cancer May Open the Door to Better Diagnosis and Treatments More

Career Center

• AI in Biotech: The New Frontier for Leadership & Strategy More
• 11 Companies Hiring Now in New York More
  
• Empowering Students Through STEM: A Conversation With Massachusetts Science & Engineering Fair Executive Director Helen Rosenfeld More
  
• From Seed to Series C: What Investors Look for Beyond the Science More
• Hiring Outlook: February Brings First YOY Job Increase Since 2022 More
• ICYMI: CEO's Perspective: Big Moves Come with Big Responsibilities More
  
• ICYMI: CEO's Perspective: The High Cost of Job Hopping More
• ICYMI: Elevating Executive Presence: A Blueprint for Life Sciences and Biotech Leaders More
• Lilly’s Chief Technology Officer Retires After 35 Years; Astellas Strategy Exec Resigns More*
• More Than Executive Search: Building Leadership for Every Stage of Growth More

• Life Science Cares Boston 10th Annual Impact Breakfast April 13
  
• CMO Summit 360° April 13-14
• Drug Discovery Chemistry April 13-16
• IMMUNOLOGY2026 April 15-19
  
• Venture Cafe Cambridge Thursday Gathering April 16
• Advancing Rare Together - A Night at the Museum with Rare New England April 18
  
• Life Science Innovation Northwest 2026 April 21-22
  
• Southern California Life Sciences & Biotech Summit April 28
• Life Sciences PA Tailgate250 April 30
  
• Delaware’s DNA | 2026 Life Science Conference April 30
• SynBioBeta 2026 May 4-7
  
• AAPS National Biotechnology Conference May 11-14
  
• Bio-IT World Conference & Expo May 19-21

Companies

NYC Sponsors